AI in Cytology Screening Device Market Size, Share, Trends, and Forecast, 2026-2033 | 15.2% CAGR Fueled by Digital Pathology and Lab Automation
Dublin, Nov. 16, 2026 (GLOBE NEWSWIRE) -- "AI In Cytology Screening Device Market Size, Share & Trends Analysis Report 2026-2033" has been added to ResearchAndMarkets.com's offering.
The global AI in cytology screening device market was valued at USD 106.8 million in 2025 and is projected to increase from USD 122.6 million in 2026 to USD 330.9 million by 2033. The market is expected to expand at a CAGR of 15.2% from 2026 to 2033, driven by shortages of skilled cytologists and growing demand for AI-enabled screening solutions that improve diagnostic accuracy, reduce manual workloads, and enhance laboratory efficiency.
North America accounted for the largest revenue share of 39.9% in 2025. The region's leadership is supported by strong research and development capabilities, established reimbursement infrastructure, investment in digital pathology, supportive regulatory frameworks, and expanding cervical cancer screening programs. Market participants are also strengthening distribution networks, commercial operations, and strategic collaborations to increase access to AI-assisted cytology technologies.
Market Innovation and Competitive Landscape
The market demonstrates a high level of innovation, supported by advances in artificial intelligence, deep learning, digital pathology, whole-slide imaging, and computational image analysis. Manufacturers are developing AI-enabled platforms that automate slide evaluation, detect abnormal cellular changes, and integrate with digital pathology workflows. Continued investment in research and development, laboratory automation, and clinical validation is accelerating product development and adoption.
In February 2024, Hologic received U.S. FDA 510(k) clearance for the Genius Digital Diagnostics System, the first AI-powered digital cytology platform approved for cervical cancer screening. The platform combines deep learning and advanced volumetric imaging to assist laboratories in identifying suspicious cervical cells. Its improved diagnostic performance compared with conventional microscopic review represents an important milestone for AI-enabled cytology screening.
Merger and acquisition activity remains moderate because the market is highly specialized. Transactions generally focus on strengthening digital pathology capabilities, artificial intelligence expertise, and women's health diagnostics. In April 2026, Blackstone and TPG completed the acquisition of Hologic. The transaction is expected to support continued investment in Hologic's diagnostic technology portfolio, including its Genius Digital Diagnostics System, ThinPrep products, and other AI-enabled cytology solutions.
Regulatory and Product Expansion Trends
Regulatory requirements have a significant influence on market development by governing the clinical validation, safety, performance, and commercialization of AI-enabled diagnostic systems. Frameworks established by the U.S. FDA and European regulators promote diagnostic reliability and strengthen confidence in clinically validated technologies. Regulatory clearances and approvals are therefore critical to commercial adoption across hospitals and diagnostic laboratories.
Product expansion is another important competitive strategy. Manufacturers are building integrated cervical cancer screening portfolios that support clinical adoption and improve workflow efficiency. In February 2026, Hologic received U.S. FDA approval for an expanded indication of its Aptima HPV Assay for primary HPV screening. The expanded indication broadens the company's cervical health portfolio across Pap testing, HPV primary screening, and co-testing while complementing its AI-enabled digital cytology platform.
Market Segmentation
The report provides global, regional, and country-level revenue forecasts and analyzes industry trends across product, deployment, application, end-use, and regional segments from 2021 to 2033.
Product Outlook (Revenue, USD Million, 2021 - 2033)
Deployment Outlook (Revenue, USD Million, 2021 - 2033)
Application Outlook (Revenue, USD Million, 2021 - 2033)
End-use Outlook (Revenue, USD Million, 2021 - 2033)
Regional Outlook (Revenue, USD Million, 2021 - 2033)
Key Benefits of the Report
The report enables healthcare technology companies, diagnostic laboratories, investors, and other stakeholders to evaluate growth opportunities in the AI in cytology screening device market. It also supports strategic decision-making by examining regulatory developments, competitive positioning, regional demand, product innovation, and the expanding role of AI-enabled digital cytology in cervical cancer screening and other clinical applications.
Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Market Definitions
1.1.2. Product
1.1.3. Deployment
1.1.4. Application
1.1.5. End user
1.2. Research Methodology
1.3. Estimates and Forecast Timeline
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. The internal database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers
3.4.1. Growing Shortage of Skilled Cytologists and Pathologists
3.4.2. Technological Advancements in AI-Based Image Analysis and Whole-Slide Imaging
3.4.3. Increasing Incidence of Cervical Cancer and Growing Need for Early Detection
3.4.4. Growing Demand for Automated Cytology Screening to Address Cytopathologist Workforce Shortages
3.5. Market Restraint Analysis
3.5.1. High Implementation Costs and Limited Digital Pathology Infrastructure
3.5.2. Regulatory, Validation, and Data Privacy Challenges for AI-Based Diagnostic Systems
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; by Factor (Political & Legal, Economic And Technological)
3.6.2. Porter's Five Forces Analysis
Chapter 4. Product Business Analysis
4.1. AI in Cytology Screening Device Market: Product Movement Analysis
4.2. Automated Cytology Screening Systems
4.2.1. Automated Cytology Screening Systems Market, 2021 - 2033 (USD Million)
4.3. Digital Cytology Imaging Systems
4.3.1. Digital Cytology Imaging Systems Market, 2021 - 2033 (USD Million)
4.4. AI Cytology Analysis Software
4.4.1. AI Cytology Analysis Software Market, 2021 - 2033 (USD Million)
4.5. Others
4.5.1. Others Market, 2021 - 2033 (USD Million)
Chapter 5. Deployment Business Analysis
5.1. AI in Cytology Screening Device Market: Deployment Movement Analysis
5.2. On-Premise
5.2.1. On-Premise Market, 2021 - 2033 (USD Million)
5.3. Cloud-Based
5.3.1. Cloud-Based Market, 2021 - 2033 (USD Million)
Chapter 6. Application Business Analysis
6.1. AI in Cytology Screening Device Market: Application Movement Analysis
6.2. Gynecological Cytology Screening
6.2.1. Gynecological Cytology Screening Market, 2021 - 2033 (USD Million)
6.3. Non-Gynecological Cytology Screening
6.3.1. Non-Gynecological Cytology Screening Market, 2021 - 2033 (USD Million)
Chapter 7. End Use Business Analysis
7.1. AI in Cytology Screening Device Market: End Use Movement Analysis
7.2. Hospitals
7.2.1. Hospitals Market, 2021 - 2033 (USD Million)
7.3. Diagnostic Laboratories
7.3.1. Diagnostic Laboratories Market, 2021 - 2033 (USD Million)
7.4. Academic & Research Institutes
7.4.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
7.5. Others
7.5.1. Others AI in Cytology Screening Device Market, 2021 - 2033 (USD Million)
Chapter 8. Regional Business Analysis
8.1. AI in Cytology Screening Device Market Share by Region, 2025 & 2033
8.2. Country Analysis Framework
8.2.1. Key Country Dynamics
8.2.2. Target Disease Prevalence
8.2.3. Competitive Scenario
8.2.4. Regulatory Framework
8.2.5. Reimbursement Scenario
8.2.6. Market Estimates, 2021 - 2033 (USD Million)
8.3. North America
8.3.1. North America AI in cytology screening device market, 2021 - 2033 (USD Million)
8.3.2. U.S.
8.3.3. Canada
8.3.4. Mexico
8.4. Europe
8.4.1. Europe AI in cytology screening device market, 2021 - 2033 (USD Million)
8.4.2. Germany
8.4.3. UK
8.4.4. France
8.4.5. Italy
8.4.6. Spain
8.4.7. Denmark
8.4.8. Sweden
8.4.9. Norway
8.5. Asia Pacific
8.5.1. Asia Pacific AI in cytology screening device market, 2021 - 2033 (USD Million)
8.5.2. Japan
8.5.3. China
8.5.4. India
8.5.5. South Korea
8.5.6. Australia
8.5.7. Thailand
8.6. Latin America
8.6.1. Latin America AI in cytology screening device market, 2021 - 2033 (USD Million)
8.6.2. Brazil
8.6.3. Argentina
8.7. MEA
8.7.1. MEA AI in cytology screening device market, 2021 - 2033 (USD Million)
8.7.2. South Africa
8.7.3. Saudi Arabia
8.7.4. UAE
8.7.5. Kuwait
Chapter 9. Competitive Landscape
9.1. Participant's overview
9.2. Financial performance
9.3. Participant categorization
9.3.1. Market Leaders
9.3.2. AI in Cytology Screening Device Market Share Analysis, 2025
9.3.3. Company Profiles
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Companies Profiled
9.3.4.1. Hologic, Inc.
9.3.4.2. Landing AI
9.3.4.3. Wuhan Konfoong Bioinformation Tech Co., Ltd. (KFBIO)
9.3.4.4. Leica Biosystems (a Danaher company)
9.3.4.5. Techcyte, Inc.
9.3.4.6. F. Hoffmann-La Roche Ltd
9.3.4.7. Becton, Dickinson and Company
9.3.4.8. OptraSCAN, Inc.
9.3.4.9. Koninklijke Philips N.V.
9.3.4.10. CellSolutions, LLC
9.3.4.11. Aiforia Technologies Plc
9.3.5. Strategy Mapping
9.3.5.1. Expansion
9.3.5.2. Acquisition
9.3.5.3. Collaborations
9.3.5.4. Disease Type/Drug Class Launch
9.3.5.5. Partnerships
9.3.5.6. Others
List of Tables [122]
List of Figures [61]
Companies Featured
For more information about this report visit https://www.researchandmarkets.com/r/pc2rem
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.